Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.170
+0.120 (5.85%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Vistagen Therapeutics Employees
As of March 31, 2024, Vistagen Therapeutics had 40 total employees, including 39 full-time and 1 part-time employees. The number of employees increased by 6 or 17.65% compared to the previous year.
Employees
40
Change (1Y)
6
Growth (1Y)
17.65%
Revenue / Employee
$17,450
Profits / Employee
-$1,182,600
Market Cap
62.92M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
VTGN News
- 6 days ago - Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference - Business Wire
- 5 weeks ago - Vistagen to Present at the 2025 Anxiety and Depression Association Conference - Business Wire
- 7 weeks ago - Vistagen to Participate in Stifel 2025 Virtual CNS Forum - Business Wire
- 2 months ago - Vistagen to Participate in the 45th Annual TD Cowen Healthcare Conference - Business Wire
- 2 months ago - Vistagen: Pherine Candidate Proof Of Concept Continues With Fifth Indication - Seeking Alpha
- 2 months ago - Vistagen Therapeutics, Inc. (VTGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update - Business Wire
- 2 months ago - Vistagen to Report Fiscal Year 2025 Third Quarter Results and Host Corporate Update Conference Call on February 13, 2025 - Business Wire